Organization Overview
Alternative names
allogeneic adipose derived mesenchymal stem cell (1 trial)
allogeneic stem cells (2 trials)
autologous mononuclear stem cell (1 trial)
burosumab-twza (crysvita) (1 trial)
carfilzomib (kyprolis) (1 trial)
cisplatin (platinol) (2 trials)
cytarabine (cytosar-u) (1 trial)
allogeneic b-lymphocytes (1 trial)
allogeneic central memory t cells (1 trial)
autologous dendritic cells loaded with autologous tumor lysate (1 trial)
cabozantinib (cometriq) (1 trial)
caspofungin (cancidas) (1 trial)
cyclophosphamide (cytoxan) (3 trials)
Acquired Immunodeficiency Syndrome (Phase 2)
Acromegaly (Phase 4)
Addison Disease (Phase 2)
Adrenal Gland Neoplasms (Phase 2)
Adrenal Insufficiency (Phase 2)
Adrenocortical Carcinoma (Phase 3)
Anemia, Aplastic (Phase 2)
Atrial Fibrillation (Phase 3)
Carcinoma (Phase 3)
Cerebral Hemorrhage (Phase 3)
Disease Progression (Phase 2)
Edema (Phase 3)
Familial Hypophosphatemic Rickets (Phase 3)
Fibromyalgia (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Heart Failure (Phase 4)
Hemorrhage (Phase 3)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 2)
Hypertrophy (Phase 4)
Hypertrophy, Left Ventricular (Phase 4)
Hypophosphatemia (Phase 3)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 2)
Kidney Neoplasms (Phase 1)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Non-Hodgkin (Phase 1)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Melanoma (Phase 3)
Multiple Myeloma (Phase 3)
Mycoses (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myofascial Pain Syndromes (Phase 2)
Neoplasms, Plasma Cell (Phase 3)
Schizophrenia (Phase 4)
Sepsis (Phase 4)
Syndrome (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Uveal Neoplasms (Phase 3)
Waldenstrom Macroglobulinemia (Phase 2)